Sign In

Philip Low

Chairman, CEO & Founder, NeuroVigil; iBrain Inventor; Cambridge Declaration on Consciousness Author.

Professional Background

Philip Low is a distinguished leader in the field of neuroscience and technology, recognized for his innovative contributions and unwavering commitment to advancing human health and understanding of the brain. He is the founder, chairman, and Chief Executive Officer of Neurovigil, Inc., a cutting-edge company specializing in neurotechnology and brain monitoring solutions. Under his leadership, Neurovigil has been at the forefront of developing advanced tools for brain health assessment, which has revolutionized the way we understand neurological conditions and cognitive function.

With a rich and diverse career spanning multiple esteemed institutions, Philip has played vital roles in several prominent organizations. His expertise has been sought after across various platforms; he served as a review editor for Frontiers, where he contributed to the advancement of academic publishing in neurosciences. Additionally, he took on the role of life sciences advisor at Xprize, further emphasizing his commitment to creating impactful solutions for global challenges in health.

Prior to his entrepreneurial ventures, Philip honed his research skills as a research affiliate at the Massachusetts Institute of Technology (MIT), and as an adjunct professor at Stanford University School of Medicine. His wealth of experience in academic institutions endowed him with a strong theoretical foundation in computational neurobiology, a field he dived into during his PhD at the renowned Salk Institute for Biological Studies. His time spent as a research associate at both The University of Chicago and Harvard Medical School solidified his standing as an expert in neuroscience and laid the groundwork for his future accomplishments.

Education and Achievements

Philip Low's academic journey started at the University of Chicago, where he earned his Bachelor of Science in Mathematics. This strong mathematical background provided him with a robust analytical framework that he has applied throughout his career, particularly in understanding complex neurobiological systems. Philip further advanced his education by pursuing a Doctor of Philosophy at the University of California, San Diego, focusing on computational neurobiology, which enabled him to merge his interests in mathematics, biology, and technology.

His studies at the esteemed Institute Le Rosey equipped him with a unique perspective on interdisciplinary education and critical thinking that continues to inform his professional pursuits. The exceptional environment at Le Rosey played a key role in shaping his approach to problem-solving and innovation.

Philip’s achievements are not merely academic; they are grounded in real-world impact. His work as a scientific advisor for the Aspen Brain Forum and as a special projects advisor at The Science Network underscores his dedication to furthering the conversation around brain science, technology, and policy. In addition, his tenure on the Board of Directors for the Organization for Computational Neurosciences showcases his commitment to fostering collaboration and knowledge sharing among leading professionals in the field.

Notable Contributions

Philip Low's impact in the field of neurotechnology is profound. As CEO of Neurovigil, Inc., he has pioneered advancements that have laid the groundwork for future neurodiagnostic tools and therapies. His insights have driven innovative solutions that leverage technology to improve mental health and cognitive disorders. Neurovigil's work in mapping brain activity through non-invasive techniques has attracted attention worldwide, positioning the company as a leader in this essential frontier.

His academic and research endeavors have also garnered him recognition as an authoritative figure in computational neurobiology. With his experience at prestigious institutions like MIT and Harvard, he brings a rigorous and well-respected academic perspective to his work in the tech industry.

Moreover, Philip Low's engagement with the broader scientific community—through roles such as review editor and life sciences advisor—demonstrates his ongoing commitment to the field. His ability to bridge the gap between academia and practical application is a testament to his vision of harnessing science for the greater good.

In summary, Philip Low’s multifaceted career is characterized by his relentless pursuit of knowledge, innovative thinking, and a firm belief in the potential of technology to improve human life. As he continues to lead Neurovigil, his contributions to neuroscience and technology remain a source of inspiration to current and future generations of scientists, entrepreneurs, and innovators.

Highlights

May 18 · Endpoints News
Morphimmune, the biotech that hired Clay Siegall, raises $15M - Endpoints News
Morphimmune, the biotech that hired Clay Siegall, raises $15M - Endpoints News
Aug 16 · Endpoints News
Two years post-merger, Flagship's Senda refines pipeline and ... - Endpoints News
Two years post-merger, Flagship's Senda refines pipeline and ... - Endpoints News

Related Questions

How did Philip Low transition from his academic background in mathematics to founding a neurotechnology company?
What specific challenges did Philip Low face during the development of Neurovigil, Inc.?
In what ways has Philip Low's education at the University of Chicago influenced his professional approach?
How has Philip Low contributed to shaping policies around brain health through his advisory roles?
What impact has Philip Low made in the field of computational neurobiology during his tenure at MIT and Harvard?
Philip Low
Add to my network

Location

San Francisco Bay Area